NK- and T-cell lymphoma of the nasal cavity and paranasal sinuses in Denmark 1980–2017: a nationwide cohort study

References

• Vose J, Armitage J, Weisenburger D. International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol. 2008;26(25):4124–4130.
   PubMed Web of Science ®Google Scholar
• William BM, Armitage JO. International analysis of the frequency and outcome of NK/T-cell lymphoma. Best Pract Res Clin Haematol. 2013;26(1):23–32.
   PubMed Web of Science ®Google Scholar
• Chihara D, Ito H, Matsuda T, et al. Differences in incidence and trends of haematological malignancies in Japan and the United States. Br J Haematol. 2014;164;(4):536–545.
   PubMed Web of Science ®Google Scholar
• Sun J, Yang Q, Lu Z, et al. Distribution of lymphoid neoplasms in China: analysis of 4,638 cases according to the World Health Organization classification. Am J Clin Pathol. 2012;138(3):429–434.
   PubMed Web of Science ®Google Scholar
• Swerdlow S, Campo E, Jaffe E. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Vol. 2. Lyon: WHO; 2017.
   Google Scholar
• Li YX, Liu QF, Fang H, et al. Variable clinical presentations of nasal and waldeyer ring natural killer/T-cell lymphoma. Clin Cancer Res. 2009;15(8):2905–2912.
   PubMed Web of Science ®Google Scholar
• Kommalapati A, Tella SH, Ganti AK, et al. Natural killer/T-cell neoplasms: analysis of incidence, patient characteristics, and survival outcomes in the United States. Clin Lymphoma Myeloma Leuk. 2018;18(7):475–479.
   PubMed Web of Science ®Google Scholar
• Tse E, Kwong YL. How I treat NK/T-cell lymphomas. Blood. 2013;121;(25):4997–5005.
   PubMed Web of Science ®Google Scholar
• Weisenburger D, Savage K, Harris N, et al. Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the international peripheral T-cell lymphoma project. Blood. 2011;117(12):3402–3408.
   PubMed Web of Science ®Google Scholar
• Al-Zahrani M, Savage KJ. Peripheral T-cell lymphoma, not otherwise specified. Hematol Oncol Clin North Am. 2017;31(2):189–207.
   PubMed Web of Science ®Google Scholar
• Statics Denmark. Denmark in figures [Internet]. 2019. Statistics Denmark. Available from: https://www.dst.dk/Site/Dst/Udgivelser/GetPubFile.aspx?id=28924&sid=dkinfigures2019.
   Google Scholar
• Cortese G, Scheike TH. Dynamic regression hazards models for relative survival. Stat Med. 2008;27(18):3563–3584.
   PubMed Web of Science ®Google Scholar
• Statistics Denmark. https://www.dst.dk/en/Statistik/nyt/relateret?eid=10015.
   Google Scholar
• Therneau T, Lumley T. Package ‘survival’. https://cran.r-project.org/web/packages/survival/survival.pdf.
   Google Scholar
• Scheike TH. Package ‘timereg’. https://cran.r-project.org/web/packages/timereg/timereg.pdf. 2020.
   Google Scholar
• Cheson BD, Horning SJ, Coiffier B, et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J Clin Oncol. 1999;17(4):1244–1244.
   PubMed Web of Science ®Google Scholar
• Danish Lymphoma Group. LYFO annually reports [Internet]. Available from: http://www.lymphoma.dk/arsrapporter/.
   Google Scholar
• Ai WZ, Chang ET, Fish K, et al. Racial patterns of extranodal natural killer/T-cell lymphoma, nasal type, in California: a population-based study. Br J Haematol. 2012;156(5):626–632.
   PubMed Web of Science ®Google Scholar
• Au W-Y, Ma S-Y, Chim C-S, et al. Clinicopathologic features and treatment outcome of mature T-cell and natural killer-cell lymphomas diagnosed according to the world health organization classification scheme: a single center experience of 10 years. Ann Oncol. 2005;16(2):206–214.
   PubMed Web of Science ®Google Scholar
• Au WY, Gascoyne RD, Klasa RD, et al. Incidence and spectrum of non-Hodgkin lymphoma in Chinese migrants to British Columbia. Br J Haematol. 2005;128(6):792–796.
   PubMed Web of Science ®Google Scholar
• Brown PdN, Jørgensen J, Munksgaard L. Dansk LymfomGruppe (DLG). Malignt Lymfom I Danmark. Annual report. 2011. [cited 2022 May 30]. lymphoma.dk.
   Google Scholar
• Jin Kim S, Soo Kim B, Won Choi C, et al. Treatment outcome of front-line systemic chemotherapy for localized extranodal NK/T cell lymphoma in nasal and upper aerodigestive tract. Leuk Lymphoma. 2006;47(7):1265–1273. Jan 1
   PubMed Web of Science ®Google Scholar
• Pagano L, Gallamini A, Trapè G, et al. NK/T-cell lymphomas 'nasal type': an Italian multicentric retrospective survey. Ann Oncol. 2006;17(5):794–800.
   PubMed Web of Science ®Google Scholar
• Rozas-Muñoz E, Gallardo F, Pujol R, et al. Extranodal natural killer/T-cell lymphoma, nasal type: a Spanish multicentric retrospective survey. Eur J Dermatol EJD. 2018;28(1):64–70.
   PubMed Web of Science ®Google Scholar
• Kim T, Lee SY, Jeon Y, et al. Clinical heterogeneity of extranodal NK/T-cell lymphoma, nasal type: a national survey of the Korean Cancer Study Group. Ann Oncol. 2008;9(8):1477–1484.
   Google Scholar
• Liu Q-F, Wang W-H, Wang S-L, et al. Immunophenotypic and clinical differences between the nasal and extranasal subtypes of upper aerodigestive tract natural killer/T-cell lymphoma. Int J Radiat Oncol Biol Phys. 2014;88(4):806–813.
   PubMed Web of Science ®Google Scholar
• Au W y, Weisenburger DD, Intragumtornchai T, et al. Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the international peripheral T-cell lymphoma project. Blood. 2009;113(17):3931–3937.
   PubMed Web of Science ®Google Scholar
• Mellgren K, Attarbaschi A, Abla O, et al. Non-anaplastic peripheral T cell lymphoma in children and adolescents—an international review of 143 cases. Ann Hematol. 2016;95;(8):1295–1305.
   PubMed Web of Science ®Google Scholar
• Niu SQ, Yang Y, Li YY, et al. Primary site and regional lymph node involvement are independent prognostic factors for early-stage extranodal nasal-type natural killer/T cell lymphoma. Chin J Cancer. 2016;35(1):34.
   PubMedGoogle Scholar
• Li YX, Yao B, Jin J, et al. Radiotherapy as primary treatment for stage IE and IIE nasal natural killer/T-Cell lymphoma. J Clin Oncol. 2006;24(1):181–189.
   PubMed Web of Science ®Google Scholar
• Isobe K, Uno T, Tamaru J I, et al. Extranodal natural killer/T-cell lymphoma, nasal type: the significance of radiotherapeutic parameters. Cancer. 2006;106(3):609–615.
   PubMed Web of Science ®Google Scholar